Roberto Mignone sold $14.4M of Teva Pharmaceutical Industries Limited (TEVA)

Executed Sep 18, disclosed Sep 22, 4 days later.

Value, as filed

$14.4M

367,600 sh × $39.06

Executed

Sep 18

the trade date, as filed

Disclosed

Sep 22

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Roberto Mignone Director profile →

Roberto Mignone (Director) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Teva Pharmaceutical Industries Limited (TEVA). The largest single filing was $14.4M of TEVA (367,600 sh × $39.06, as filed), executed Sep 18.

The name

TEVA

Teva Pharmaceutical Industries Limited TEVA · Healthcare · 58 filings in 24 months ticker →

Healthcare · Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Roberto Mignone in TEVA

TEVASALE Teva Pharmaceutical Industries Limited $2.3M
77,400 sh × $30.24
Exec Dec 16 2025
Filed Dec 18 2025 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited $1.3M
50,000 sh × $26.03
Exec Nov 26 2025
Filed Dec 1 2025 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited $4.8M
200,000 sh × $24.11
Exec Nov 6 2025
Filed Nov 10 2025 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited $6.3M
286,000 sh × $22.01
Exec Dec 20 2024
Filed Dec 26 2024 · 5:30 PM ET †